Back to Browse Journals » Open Access Medical Statistics » Volume 1

Projection of long-term outcomes using X-rays and pooled cytology in lung cancer screening

Authors Wu D, Erwin D, Kim S

Published Date August 2011 Volume 2011:1 Pages 13—19

DOI http://dx.doi.org/10.2147/OAMS.S22987

Published 2 August 2011

Dongfeng Wu1, Diane Erwin2, Seongho Kim1
1Department of Bioinformatics and Biostatistics, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, 2Information Management Services, Inc, Rockville, MD, USA

Purpose: To investigate the long-term outcome of using X-ray and the 3-day "pooled" sputum cytology in lung cancer screening using the Mayo Lung Project data.
Methods: In this study, the statistical method developed by the authors using the Mayo Lung Project data was applied. Each participant eventually falls into one of the four categories depending on whether they would be diagnosed with lung cancer and whether symptoms would have appeared before death. The derived probability of each outcome was presented. Bayesian inference was made for the percentages of true-early-detection, no-early-detection, over-diagnosis, and symptom-free-life. The authors present estimates of these proportions for male heavy smokers by using Markov Chain Monte Carlo samples in the simulation. Human lifetime was treated as a random variable.
Results: The probability that a male heavy smoker will live a lung cancer-free life is about 80%; the probability for developing lung cancer for a male heavy smoker is about 20%, much higher than in the general population (6.95%). The probability of over-diagnosis is low, about 6%–9% among the early detected cases. The probability of true-early-detection is greater than 90%. Finally, the probability of no-early-detection increases as the screening interval increases; among the diagnosed cases, it is about 15% if the screens are 6 months apart, and it is close to 50% if the screens are 2 years apart.
Conclusion: This research provides a framework and a systematic approach for policy makers regarding how to evaluate long-term outcomes of chest X-ray and pooled sputum cytology in lung cancer screening.

Keywords:
true early detection, no early detection, over diagnosis, symptom-free life, pooled sputum cytology

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Meeting the needs of medical research with statistical methods

Wu D

Open Access Medical Statistics 2011, 1:1-2

Published Date: 27 April 2011

Readers of this article also read:

Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment

Gui T, Yuan GW, Shen K, Cao DY, Yang JX, Wu M, Lang JH

OncoTargets and Therapy 2015, 8:661-667

Published Date: 23 March 2015

Prognostic role of apoptosis-related gene functional variants in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy

Tao KY, Li XX, Xu WZ, Wang Y, Zhu SM, Xie HX, Luo WH, Xu YJ, Xu XL

OncoTargets and Therapy 2015, 8:147-155

Published Date: 14 January 2015

Physicochemical and functional characterization of a biosimilar adalimumab ZRC-3197

Bandyopadhyay S, Mahajan M, Mehta T, Singh AK, Parikh A, Gupta AK, Kalita P, Patel M, Mendiratta SK

Biosimilars 2015, 5:1-18

Published Date: 31 December 2014

Recent advances in the development of breast cancer vaccines

Milani A, Sangiolo D, Aglietta M, Valabrega G

Breast Cancer: Targets and Therapy 2014, 6:159-168

Published Date: 14 October 2014

Psoriasis and cardiovascular disease: epidemiology, mechanisms, and clinical implications

Pearson KC, Armstrong AW

Psoriasis: Targets and Therapy 2012, 2:1-11

Published Date: 13 January 2012

Racial differences in tumor necrosis factor-α-induced endothelial microparticles and interleukin-6 production

Brown MD, Feairheller DL, Thakkar S, Veerabhadrappa P, Park JY

Vascular Health and Risk Management 2011, 7:541-550

Published Date: 26 August 2011